Pharmacogenomic and clinical data link non-pharmacokinetic metabolic dysregulation to drug side effect pathogenesis
暂无分享,去创建一个
Aarash Bordbar | Daniel C. Zielinski | Bernhard O Palsson | Markus J. Herrgård | Daniel C Zielinski | Monica L. Mo | Kasper Jensen | Fabian V Filipp | Jeffrey W. Smith | B. Palsson | A. Bordbar | D. Zielinski | F. Filipp | Kasper Jensen | Jeffrey W Smith | Markus J Herrgard | Monica L Mo
[1] D. Ballinger,et al. A Broad Role for the Zinc Finger Protein ZNF202 in Human Lipid Metabolism* , 2000, The Journal of Biological Chemistry.
[2] Neema Jamshidi,et al. Linkage of Organic Anion Transporter-1 to Metabolic Pathways through Integrated “Omics”-driven Network and Functional Analysis* , 2011, The Journal of Biological Chemistry.
[3] David S. Wishart,et al. DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..
[4] P. Bugelski. Genetic aspects of immune-mediated adverse drug effects , 2005, Nature Reviews Drug Discovery.
[5] Jeffrey P. Jones,et al. Clinical and toxicological relevance of CYP2C9: drug-drug interactions and pharmacogenetics. , 2005, Annual review of pharmacology and toxicology.
[6] Marko Sysi-Aho,et al. A Systems Biology Strategy Reveals Biological Pathways and Plasma Biomarker Candidates for Potentially Toxic Statin-Induced Changes in Muscle , 2006, PloS one.
[7] Yusuke Nakamura,et al. Genome-wide association study of epirubicin-induced leukopenia in Japanese patients , 2011, Pharmacogenetics and genomics.
[8] P. Thompson,et al. The role of coenzyme Q10 in statin-associated myopathy: a systematic review. , 2007, Journal of the American College of Cardiology.
[9] Zachary A. King,et al. Constraint-based models predict metabolic and associated cellular functions , 2014, Nature Reviews Genetics.
[10] O. Carnevali,et al. Appetite regulation: The central role of melatonin in Danio rerio , 2010, Hormones and Behavior.
[11] Joseph G Ibrahim,et al. UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. , 2007, Journal of the National Cancer Institute.
[12] H. Jürgens,et al. Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin , 2000, Anti-cancer drugs.
[13] F. Collins,et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.
[14] D. Sheridan,et al. Contribution of nitric oxide and prostanoids to the cardiac electrophysiological and coronary vasomotor effects of diadenosine polyphosphates. , 2001, The Journal of pharmacology and experimental therapeutics.
[15] A. Hajrasouliha,et al. Reduced susceptibility to epinephrine-induced arrhythmias in cirrhotic rats: the roles of nitric oxide and endogenous opioid peptides. , 2007, Journal of hepatology.
[16] Thomas Gasser,et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria , 2009, The Lancet Neurology.
[17] V. Arolt,et al. Severe Tardive Dyskinesia in Affective Disorders: Treatment with Vitamin E and C , 2003, Neuropsychobiology.
[18] M. Hayden,et al. Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy , 2013, Nature Genetics.
[19] Vladimir I. Vladimirov,et al. Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects , 2010, Biological Psychiatry.
[20] Y. Shibamoto,et al. The ZFHX3 (ATBF1) transcription factor induces PDGFRB, which activates ATM in the cytoplasm to protect cerebellar neurons from oxidative stress , 2010, Disease Models & Mechanisms.
[21] A. Rettie,et al. Cytochrome P450 2C8: Substrates, Inhibitors, Pharmacogenetics, and Clinical Relevance , 2005, Clinical pharmacology and therapeutics.
[22] L. Angelis. Ascorbic acid and atypical antipsychotic drugs: modulation of amineptine-induced behavior in mice , 1995, Brain Research.
[23] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[24] Bernhard O. Palsson,et al. Connecting Extracellular Metabolomic Measurements to Intracellular Flux States in Yeast , 2022 .
[25] C. Lavie,et al. Coenzyme q10 and statin-induced mitochondrial dysfunction. , 2010, The Ochsner journal.
[26] J. Tamargo,et al. Cardiac electrophysiological effects of nitric oxide. , 2010, Cardiovascular research.
[27] Clement Hamani,et al. Contribution of Decreased Serotonin Release to the Antidyskinetic Effects of Deep Brain Stimulation in a Rodent Model of Tardive Dyskinesia: Comparison of the Subthalamic and Entopeduncular Nuclei , 2012, The Journal of Neuroscience.
[28] M. Frieri,et al. Theophylline inhibits the production of nitric oxide by peripheral blood mononuclear cells from patients with asthma. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[29] J. Nielsen,et al. Uncovering transcriptional regulation of metabolism by using metabolic network topology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[30] I. Cameron,et al. Consumption of an omega-3 fatty acids product, INCELL AAFA™, reduced side-effects of CPT-11 (irinotecan) in mice , 2002, British Journal of Cancer.
[31] Peter H. Langsjoen,et al. Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation , 2005, BioFactors.
[32] E. J. van den Oord,et al. Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D , 2012, Translational Psychiatry.
[33] E. Tan,et al. Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor , 2001, Biological Psychiatry.
[34] B. Lerer,et al. Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia , 2003, The Pharmacogenomics Journal.
[35] J. Makielski,et al. Redox control of cardiac excitability. , 2013, Antioxidants & redox signaling.
[36] G. Rozanski,et al. Glutathione and K(+) channel remodeling in postinfarction rat heart. , 2002, American journal of physiology. Heart and circulatory physiology.
[37] Russell A. Wilke,et al. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges , 2007, Nature Reviews Drug Discovery.
[38] S. O’Rahilly,et al. The central melanocortin system directly controls peripheral lipid metabolism. , 2007, The Journal of clinical investigation.
[39] Nir Giladi,et al. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia. , 2000, The American journal of psychiatry.
[40] R. Shah,et al. Pharmacogenetic Aspects of Drug-Induced Torsade de Pointes , 2004, Drug safety.
[41] S. Priori,et al. Evidence for a Cardiac Ion Channel Mutation Underlying Drug‐Induced QT Prolongation and Life‐Threatening Arrhythmias , 2000, Journal of cardiovascular electrophysiology.
[42] C. Nichols,et al. Polyamine transport by the polyspecific organic cation transporters OCT1, OCT2, and OCT3. , 2013, Molecular pharmaceutics.
[43] Doheon Lee,et al. Building the process-drug–side effect network to discover the relationship between biological Processes and side effects , 2011, BMC Bioinformatics.
[44] R. Chahine,et al. Protective effects of taurine against reperfusion-induced arrhythmias in isolated ischemic rat heart. , 1998, Arzneimittel-Forschung.
[45] S. Vollset,et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. , 2009, JAMA.
[46] M. Ingelman-Sundberg,et al. Genetic polymorphism and toxicology--with emphasis on cytochrome p450. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[47] V. Steen,et al. Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients , 1997, Molecular Psychiatry.
[48] M. Rieder,et al. Novel Rare Variants in Congenital Cardiac Arrhythmia Genes are Frequent in Drug-induced Torsades de Pointes , 2012, The Pharmacogenomics Journal.
[49] U. Meyer. Pharmacogenetics and adverse drug reactions , 2000, The Lancet.
[50] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[51] J. Sykes,et al. Effects of retinal and pineal low molecular weight fractions and antipsychotic drugs on hydroxyindole-O-methyltransferase , 2005, Journal of Neural Transmission.
[52] R. Buzina,et al. Vitamin C status in chronic schizophrenia , 1990, Biological Psychiatry.
[53] M. Angermeyer,et al. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. , 2003, Pharmacopsychiatry.
[54] Rune Dahlqvist,et al. Adverse drug reactions as a cause for admissions to a department of internal medicine , 2002, Pharmacoepidemiology and drug safety.
[55] Desmond S. Lun,et al. Interpreting Expression Data with Metabolic Flux Models: Predicting Mycobacterium tuberculosis Mycolic Acid Production , 2009, PLoS Comput. Biol..
[56] N. Dhalla,et al. Antiarrhythmic Effects of Some Antioxidant Vitamins in Rats Injected with Epinephrine , 2009, Cardiovascular Toxicology.
[57] A. Mohamadin,et al. Does oxidative stress contribute in tricyclic antidepressants-induced cardiotoxicity? , 2004, Toxicology letters.
[58] R. Chahine,et al. Protective effect of taurine against free radicals damage in the rat myocardium. , 2004, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[59] S. Lalani,et al. Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency. , 2005, Archives of neurology.
[60] Ronan M. T. Fleming,et al. A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.
[61] Monica L. Mo,et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.
[62] A. Daly. Using genome-wide association studies to identify genes important in serious adverse drug reactions. , 2012, Annual review of pharmacology and toxicology.
[63] G. Wegener,et al. Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity , 2003, Brain Research.
[64] Dan M Roden,et al. Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia. , 2012, Journal of the American College of Cardiology.
[65] D. Ilstrup,et al. A Double-blind, Placebo-Controlled Study , 2017 .
[66] Mancheva-Ganeva Velina,et al. Licensed under Creative Commons Attribution Cc by Oxidative Stress in Parkinson's Disease , 2022 .
[67] P. C. Viswanathan,et al. Mutation in Glycerol-3-Phosphate Dehydrogenase 1–Like Gene (GPD1-L) Decreases Cardiac Na+ Current and Causes Inherited Arrhythmias , 2007, Circulation.
[68] S. Dimauro,et al. Coenzyme Q10 deficiency and isolated myopathy , 2006, Neurology.
[69] F. Sesti,et al. N‐glycosylation‐dependent block is a novel mechanism for drug‐induced cardiac arrhythmia , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[70] N. Bresolin,et al. Muscle coenzyme Q10 level in statin-related myopathy. , 2005, Archives of neurology.
[71] J. Kim,et al. Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARα , 2004, Molecular and Cellular Endocrinology.
[72] J. S. San Miguel,et al. Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis. , 2008, Blood.
[73] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[74] Joanna M. Young,et al. Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure. , 2005, Atherosclerosis.
[75] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[76] G. Littarru,et al. Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled Study , 1993, Journal of clinical pharmacology.
[77] D. Troyer,et al. Inositol phospholipid metabolism in the kidney. , 1986, Annual review of physiology.
[78] T. Morledge,et al. Coenzyme Q10: A therapy for hypertension and statin-induced myalgia? , 2010, Cleveland Clinic Journal of Medicine.
[79] G. Kelliher,et al. Effect of prostaglandin E1 on ouabain-induced arrhythmia. , 1973, European journal of pharmacology.
[80] Eric Boerwinkle,et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry , 2009, Nature Genetics.
[81] R. Sandyk,et al. The relationship of serotonin metabolism and melatonin secretion to the pathophysiology of tardive dyskinesia. , 1989, The International journal of neuroscience.
[82] M. Liberman,et al. Dopaminergic innervation of the mouse inner ear: Evidence for a separate cytochemical group of cochlear efferent fibers , 2006, The Journal of comparative neurology.
[83] S. Chowdhury,et al. Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients. , 2011, Diabetes research and clinical practice.
[84] L. Van Obbergh,et al. Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related. , 1996, Journal of hepatology.
[85] J. C. Belmonte,et al. Diseases in a dish: modeling human genetic disorders using induced pluripotent cells , 2011, Nature Medicine.
[86] A. Stalenhoef,et al. Effects of ubiquinone (coenzyme Q10) on myopathy in statin users , 2008, Current opinion in lipidology.
[87] K. Nakashima,et al. [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.
[88] Robert C. Wolpert,et al. A Review of the , 1985 .
[89] J. Smith. The prostanoids in hemostasis and thrombosis: a review. , 1980, The American journal of pathology.
[90] A. Rumbold,et al. Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. , 2009, American journal of epidemiology.
[91] R. Diasio,et al. Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics. , 2002, Pharmacogenomics.
[92] David S. Wishart,et al. DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..
[93] P. Bork,et al. A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.
[94] Alexander A. Morgan,et al. Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data , 2011, Science Translational Medicine.
[95] D. Selkoe,et al. Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with α‐synuclein genotype , 2009, Journal of neurochemistry.
[96] A. T. Demiryürek,et al. The role of nitric oxide in digoxin-induced arrhythmias in guinea-pigs. , 1999, Pharmacology & toxicology.
[97] Robert A Hegele,et al. Genetic determinants of statin intolerance , 2007, Lipids in Health and Disease.
[98] R. Reiter,et al. Obesity and metabolic syndrome: Association with chronodisruption, sleep deprivation, and melatonin suppression , 2012, Annals of medicine.
[99] Yusuke Nakamura,et al. Genome-wide association study identifies variations in 6p21.3 associated with nevirapine-induced rash. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[100] R. Wanders,et al. Rosuvastatin lowers coenzyme Q10 levels, but not mitochondrial adenosine triphosphate synthesis, in children with familial hypercholesterolemia. , 2011, The Journal of pediatrics.
[101] D. Burns,et al. Genetic association studies to detect adverse drug reactions: abacavir hypersensitivity as an example. , 2009, Pharmacogenomics.
[102] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[103] O. Lockridge. Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine. , 1990, Pharmacology & therapeutics.
[104] F. Haramburu,et al. Does age increase the risk of adverse drug reactions? , 2002, British journal of clinical pharmacology.
[105] J. Sochman,et al. Cardioprotective effects of N-acetylcysteine: the reduction in the extent of infarction and occurrence of reperfusion arrhythmias in the dog. , 1990, International journal of cardiology.
[106] T. Lumley,et al. Cerivastatin, genetic variants, and the risk of rhabdomyolysis , 2011, Pharmacogenetics and genomics.
[107] Abdulmajeed Al Abdukareem. Randomized, placebo-controlled trial , 2004, Annals of Saudi medicine.
[108] B. Davletov,et al. Alpha-synuclein, lipids and Parkinson's disease. , 2010, Progress in lipid research.
[109] M. Phillips,et al. The role of the skeletal muscle ryanodine receptor gene in malignant hyperthermia. , 1992, Symposia of the Society for Experimental Biology.
[110] H. Eichler,et al. Drug reimbursement: indicators of inappropriate resource allocation. , 2002, British journal of clinical pharmacology.
[111] Sarah J. Wheelan,et al. Integrated Analysis of Drug-Induced Gene Expression Profiles Predicts Novel hERG Inhibitors , 2013, PloS one.
[112] C. Cantor,et al. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease. , 2011, Toxicology letters.
[113] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[114] Matthew J. Brauer,et al. Conservation of the metabolomic response to starvation across two divergent microbes , 2006, Proceedings of the National Academy of Sciences.
[115] E. Beutler. G6PD: population genetics and clinical manifestations. , 1996, Blood reviews.
[116] Steven A Carr,et al. Identifying the proteins to which small-molecule probes and drugs bind in cells , 2009, Proceedings of the National Academy of Sciences.
[117] C. Pichard,et al. Effects of widely used drugs on micronutrients: a story rarely told. , 2013, Nutrition.
[118] H. Nasrallah,et al. Serotonin precursor effects in tardive dyskinesia , 2004, Psychopharmacology.
[119] M. Ackerman,et al. GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A. , 2009, American journal of physiology. Heart and circulatory physiology.
[120] Jon Emery,et al. CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: A HuGEnet™ systematic review and meta-analysis , 2005, Genetics in Medicine.
[121] M. Tohyama,et al. Inhibition of myo-inositol transport causes acute renal failure with selective medullary injury in the rat. , 1998, Kidney international.
[122] F. Cicchetti,et al. Beneficial effects of dietary omega‐3 polyunsaturated fatty acid on toxin‐induced neuronal degeneration in an animal model of Parkinson's disease , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[123] A. Donker,et al. Effects of short‐term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo‐controlled trial , 2003, Journal of internal medicine.
[124] Brian O'Rourke,et al. Synchronized Whole Cell Oscillations in Mitochondrial Metabolism Triggered by a Local Release of Reactive Oxygen Species in Cardiac Myocytes* , 2003, Journal of Biological Chemistry.
[125] R. Collins,et al. SLCO1B1 variants and statin-induced myopathy--a genomewide study. , 2008, The New England journal of medicine.
[126] V. Parikh,et al. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.
[127] K. Shianna,et al. Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function. , 2011, Gastroenterology.
[128] T. Lehtimäki,et al. High‐dose statins and skeletal muscle metabolism in humans: A randomized, controlled trial , 2005, Clinical pharmacology and therapeutics.
[129] Xing-Ming Zhao,et al. Prediction of Drug Combinations by Integrating Molecular and Pharmacological Data , 2011, PLoS Comput. Biol..
[130] A. Bordbar,et al. Using the reconstructed genome‐scale human metabolic network to study physiology and pathology , 2012, Journal of internal medicine.
[131] Genetic variations in drug-induced liver injury (DILI): resolving the puzzle , 2012, Front. Gene..
[132] M. Raskind,et al. Olanzapine-Induced Weight Gain and Increased Visceral Adiposity is Blocked by Melatonin Replacement Therapy in Rats , 2007, Neuropsychopharmacology.
[133] E. Yeh,et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity , 2012, Nature Medicine.
[134] M. Pirmohamed,et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.
[135] C. Handschin,et al. Induction of drug metabolism: the role of nuclear receptors. , 2008, Pharmacological reviews.
[136] J. Ochoa,et al. Coenzyme Q10 supplementation ameliorates inflammatory signaling and oxidative stress associated with strenuous exercise , 2012, European Journal of Nutrition.
[137] K. Wegscheider,et al. Follow-up of prostaglandin plasma levels after acute myocardial infarction. , 1985, American heart journal.
[138] D. Quartermain,et al. The effect of chronic administration of sarizotan, 5-HT1A agonist/D3/D4 ligand, on haloperidol-induced repetitive jaw movements in rat model of tardive dyskinesia , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[139] R. Weinshilboum,et al. Structural basis of substrate recognition in thiopurine s-methyltransferase. , 2008, Biochemistry.
[140] R. Weinshilboum,et al. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia , 1990, The Lancet.
[141] Annette Lee,et al. Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain. , 2012, Archives of general psychiatry.
[142] W. Zijlstra,et al. Prostaglandin E 1 and cardiac arrhythmia. , 1972, European journal of pharmacology.
[143] M. Lamy,et al. Equine postanaesthetic myositis: Thromboxanes, prostacyclin and prostaglandin E2 production , 2004, Veterinary research communications.
[144] R. Reiter,et al. Ischemia/reperfusion‐induced arrhythmias in the isolated rat heart: Prevention by melatonin , 1998, Journal of pineal research.
[145] Jeffrey D Orth,et al. What is flux balance analysis? , 2010, Nature Biotechnology.
[146] Peilin Jia,et al. Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs , 2010, Molecular Psychiatry.
[147] D. Paterson,et al. Cardiac nitric oxide: emerging role for nNOS in regulating physiological function. , 2005, Pharmacology & therapeutics.
[148] J. Schuetz,et al. Role of ABCG2/BCRP in biology and medicine. , 2006, Annual review of pharmacology and toxicology.
[149] M. Niemi. Transporter Pharmacogenetics and Statin Toxicity , 2010, Clinical pharmacology and therapeutics.
[150] K. Shianna,et al. Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction. , 2010, Gastroenterology.
[151] A. Sanabria,et al. Randomized controlled trial. , 2005, World journal of surgery.
[152] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[153] M. Tuchman,et al. Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity. , 1985, The New England journal of medicine.
[154] Bernhard O. Palsson,et al. Context-Specific Metabolic Networks Are Consistent with Experiments , 2008, PLoS Comput. Biol..
[155] G. Halliday,et al. Lipid Pathway Alterations in Parkinson's Disease Primary Visual Cortex , 2011, PloS one.
[156] Olga G. Troyanskaya,et al. Coordinated Concentration Changes of Transcripts and Metabolites in Saccharomyces cerevisiae , 2009, PLoS Comput. Biol..
[157] T. Langmann,et al. The Zinc Finger Protein 202 (ZNF202) Is a Transcriptional Repressor of ATP Binding Cassette Transporter A1 (ABCA1) and ABCG1 Gene Expression and a Modulator of Cellular Lipid Efflux* , 2001, The Journal of Biological Chemistry.
[158] H. Shin,et al. Possible role of EMID2 on nasal polyps pathogenesis in Korean asthma patients , 2012, BMC Medical Genetics.
[159] S. Masuda,et al. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. , 2005, Drug metabolism and pharmacokinetics.
[160] Kiran Raosaheb Patil,et al. Contribution of Network Connectivity in Determining the Relationship between Gene Expression and Metabolite Concentration Changes , 2014, PLoS Comput. Biol..
[161] R. Naviaux,et al. Statin myotoxicity is associated with changes in the cardiopulmonary function. , 2004, Atherosclerosis.
[162] J. Arrowsmith. Trial watch: Phase III and submission failures: 2007–2010 , 2011, Nature Reviews Drug Discovery.
[163] A. Simopoulos,et al. Essential fatty acids in health and chronic disease. , 1999, The American journal of clinical nutrition.
[164] P. Reitsma,et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation , 1994, The Lancet.
[165] M. Polymeropoulos,et al. Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia , 2009, Molecular Psychiatry.
[166] M Pirmohamed,et al. Genetic susceptibility to adverse drug reactions. , 2001, Trends in pharmacological sciences.
[167] S. Dimauro,et al. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. , 2007, Brain : a journal of neurology.
[168] P. Bork,et al. Systematic identification of proteins that elicit drug side effects , 2013, Molecular systems biology.
[169] B. O’Rourke,et al. Cardiac mitochondria and arrhythmias. , 2010, Cardiovascular research.
[170] Xin Hu,et al. Impact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysis , 2012, Tumor Biology.
[171] J. Oates,et al. Platelet dysfunction in the neonate with essential fatty acid deficiency. , 1977, The Journal of pediatrics.
[172] S. Khanzode,et al. Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia , 2005, Psychopharmacology.
[173] P. Randall,et al. Simultaneous catalepsy and apomorphine-induced stereotypic behavior in mice. , 1985, Life sciences.
[174] Funda Meric-Bernstam,et al. BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer. , 2006, Cancer cell.
[175] Michael Kuhn,et al. Reflect: A practical approach to web semantics , 2010, J. Web Semant..
[176] J. Elmquist,et al. From observation to experimentation: leptin action in the mediobasal hypothalamus. , 2009, The American journal of clinical nutrition.
[177] M. Condorelli,et al. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study , 2004, The clinical investigator.
[178] Ichiro Naeshiro,et al. Similar compounds searching system by using the gene expression microarray database. , 2009, Toxicology letters.
[179] Ganesh Dakhale,et al. Oxidative Damage and Schizophrenia: The Potential Benefit by Atypical Antipsychotics , 2004, Neuropsychobiology.
[180] Ronan M. T. Fleming,et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.
[181] J. Arrowsmith. Trial watch: Phase II failures: 2008–2010 , 2011, Nature Reviews Drug Discovery.
[182] F. Schmidt. Meta-Analysis , 2008 .
[183] S. Snyder,et al. Dexras1 A G Protein Specifically Coupled to Neuronal Nitric Oxide Synthase via CAPON , 2000, Neuron.
[184] Arthur J Moss,et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome , 1995, Cell.
[185] A. Serretti,et al. The genetics of antipsychotic induced tremors: A genome‐wide pathway analysis on the STEP‐BD SCP sample , 2011, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.